预计到 2031 年,动物保健市场将从 87,547.03 百万美元增至 126,500.20 百万美元2022 年;预计 2022 年至 2031 年复合年增长率为 6.2%。
预防动物疾病和监测动物食品供应对于确保食品供应安全至关重要。饲养健康的牲畜可以保证食品的安全供应并保持销售价格的稳定。人畜共患疾病会对公共卫生、国际贸易和农业部门的稳定产生不利影响,由于牲畜贸易停止、动物屠宰和随后的疾病消除工作而造成数百万美元的损失。 2017年11月,导致仔猪死产的猪繁殖与呼吸综合征病毒(PRRSV)给美国农民造成了6亿美元的损失。因此,无疾病且健康的动物可能会带来更安全的食品供应、更高的农业生产力、减少环境影响、减少抗生素的使用。
人畜共患疾病发病率增加、蛋白质食品需求增加以及政府和动物福利协会的举措等因素预计将推动动物保健市场。然而,假药的使用以及动物药物开发和审批流程的高复杂性和成本可能会对动物保健市场的增长造成负面影响。
动物保健市场根据产品、动物类型和地理位置进行细分。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。该报告提供了对市场的洞察和深入分析,重点关注市场趋势、技术进步和市场动态等参数,并分析了全球领先市场参与者的竞争格局。
战略见解
动物保健市场利润丰厚的地区
< h3>市场洞察
越来越多地采用宠物作为陪伴
收养宠物是动物保健市场的一个重要趋势。超过 67% 的美国家庭拥有宠物,宠物总数近 4 亿只,包括狗、猫、马、鸟和鱼。根据美国防止虐待动物协会的数据,每年约有 650 万只伴侣动物进入全国动物收容所。每年进入这些收容所的狗和猫的数量比 2011 年的约 720 万有所下降。这种下降可以通过动物收养比例的增加来适度解释。根据欧洲宠物食品工业联合会 (FEDIAF) 的数据,猫仍然是欧洲家庭中最受欢迎的宠物,该地区的人口数量稳定在 7440 万。此外,狗的受欢迎程度也在不断提高,2017 年欧盟有 6,640 万只宠物狗(欧洲和俄罗斯为 8,490 万只),而 2016 年为 6,370 万(8,220 万)。
2016 年美国人在宠物上的花费超过 755 亿美元,平均家庭总支出为 100 亿美元 892 关于宠物食品、兽医服务、用品和其他服务。宠物可以改善主人的性格整体健康和福祉,并可能帮助他们活得更长。研究表明,养狗的人死于心血管疾病的风险可降低 36%,心脏病发作的风险可降低 11%。因此,收养宠物的趋势可能会推动研究期间的市场增长。
增加研发活动
在过去二十年中,开发动物保健产品的成本和时间分别增加了超过 100% 和六年。根据动物保健研究所的研究与开发调查,2006 年动物保健公司在新的潜在产品的研发以及维持所提供产品的长寿命的研究上花费了 6.63 亿美元。这比 2005 年报告的支出增加了 7%。创新研究占研发总支出的 86%,其余 14% 用于确保现有产品长期性能所需的研究。< /p>
重要参与者的投资可能进一步促进市场增长。例如,硕腾专注于持续创新,开发满足买家需求的动物健康解决方案。研发是公司努力提供创新成果的核心,这些创新成果可预测当地市场兽医和牲畜生产者的未来需求。 2021年1月30日,硕腾与科罗拉多州立大学签署协议,建立硕腾孵化器研究实验室,并开始开展研究合作,重点探索牲畜免疫系统,以开发新的免疫疗法。
< span style="font-family: verdana, generic, sans-serif; font-size: 10pt;">基于产品的见解
根据产品,动物保健市场分为处方药和非处方药。到 2022 年,处方药细分市场将占据更大的市场份额。预计在预测期内,非处方药细分市场的复合年增长率将达到 7.0%。处方药细分市场进一步细分为疫苗、药品、饲料添加剂和诊断剂。非处方药细分市场进一步分为杀虫剂、美容产品和营养品/补充剂。
基于动物类型的洞察 span>
根据动物类型,动物保健市场分为生产动物和< title="伴侣动物" href="https://www.theinsightpartners.com/zh-CN/reports/companion-animal-diagnostics-market" target="_blank" rel="noopener">伴侣动物。到 2022 年,生产动物细分市场将占据更大的市场份额。预计伴侣动物细分市场在预测期内的复合年增长率将达到 6.8%。
动物保健市场,按动物类型划分 - 2022 年和 2031 年
产品发布和并购是业内企业高度采用的策略全球动物保健市场。下面列出了最近的一些关键产品开发:
二月份2021 年,Vetoquinol SA 宣布从 Elanco Animal Health 收购 Profender 和 Drontal 产品系列。它还将收购拜耳公司动物保健业务目前拥有的知识产权、注册和其他权利。
2021 年 1 月,Nutreco NV 宣布投资荷兰公司 Kingfish Zeeland。该公司的目标是将黄尾石首鱼供应到美国和欧洲市场。分发将通过专有的循环水产养殖系统完成。
三月2021年,拜耳股份公司宣布启动Care4Pigs计划;该项目是与农场动物福利教育中心 (FAWEC) 和韩国猪兽医协会 (KASV) 合作推出的。在合作下,我们拨款 10,000 欧元用于支持旨在提高猪福祉的创新。
2021 年 2 月,硕腾的 Simparica Trio 获得 FDA 批准,这是一种针对狗的新型寄生虫预防组合。它是在美国推出的第一款每月咀嚼片,可为狗提供全方位保护,预防心丝虫病、蜱虫、跳蚤、蛔虫和钩虫。
公司简介
- 默克和Co., Inc
- 勃林格殷格翰国际有限公司
- Ceva Santé;动物
- 嘉吉公司
- 硕腾公司
- 拜耳公司
- Vetoquinol SA
- Nutreco NV
- Virbac
- Elanco
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
- Batter and Breader Premixes Market
- Investor ESG Software Market
- Authentication and Brand Protection Market
- Integrated Platform Management System Market
- Carbon Fiber Market
- Flexible Garden Hoses Market
- Battery Testing Equipment Market
- Cling Films Market
- Radiopharmaceuticals Market
- Digital Language Learning Market
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
Developing a drug for animals is much complicated and is a bit expensive. The stringent government regulations for drug approvals are the biggest hurdles in the animal health industry. The drug development process can take up to 5–7 years and cost more than US$ 10 million before entering the stage of approval. In addition, animal medicines remain heavily regulated and are subjected to strict laws that protect animals and humans, as well as the environment. Thus, drug development for animals is quite costlier, and sometimes it may become a restraint for the animal health market.
The growth of animal health market is driven by some key driving factors such as increasing incidences of zoonotic diseases, rise in demand for proteinaceous food, and initiatives by governments and animal welfare associations. However the use of counterfeit medicines, and high complexity and cost of animal drug development and approval processes are likely to restraint the market growth during the forecast period.
Similar to human animals are also affected by various diseases, which result in behavioral changes, uneasy conditions, and less production, among others. Several types of diseases can adversely affect animal health, and the diseases may include zoonotic diseases, transboundary diseases, insect-borne diseases, and diseases of production and hygiene, among others. On the other hand, animals assist in building economies through various businesses. For instance, production or livestock animals guarantee a safe supply of food and keep selling prices stable, which in return helps in earning a good income. Therefore, it is essential to maintain good animal health. Animals can be kept healthy by taking measures for their health. Animal owners should regularly take their animals to veterans to diagnose problems related to their health. The animal should be regularly given vaccines to prevent diseases. Thus, such measures assist in marinating good animal health.
Trends and growth analysis reports related to Life Sciences : READ MORE..
The List of Companies - Animal Health Market
- Merck & Co., Inc.
- Boehringer Ingelheim International GmbH
- Ceva Santé Animale
- Cargill, Incorporated
- Zoetis Inc.
- Bayer AG
- Vetoquinol SA
- Nutreco N.V
- Virbac
- Elanco
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.